|
|
|
|
|
|
|
|
1. Abbreviations
| Abbreviations |
Effective date: Sept. 1/94 |
| |
|
| ACTH |
adrenocotrophic hormone |
| ADH |
antidiuretic hormone |
| AIDS |
acquired immunodeficiency syndrome |
| ALL |
acute lymphocytic leukemia |
| AML |
acute myelogenous leukemia |
| ANC |
absolute neutrophil count |
| ASA |
aspirin |
| AST |
aspartate aminotransferase |
| ATP |
adenosine 5'-triphosphate |
| AUC |
area under the curve |
| BCCA |
British Columbia Cancer Agency |
| bid |
twice a day |
| biw |
twice a week |
| BMT |
bone marrow transplant |
| BP |
British Pharmacopoeia |
| BSA |
body surface area |
| BUN |
blood urea nitrogen |
| BWI |
bacteriostatic water for injection |
| °C |
degrees Celsius |
| CBC |
complete blood count |
| CD4 cell |
helper cell |
| CD8 cell |
suppressor cell |
| CHF |
congestive heart failure |
| Cl |
apparent total body clearance |
| cm |
centimetre(s) |
| CML |
chronic myelogenous leukemia |
| CNS |
central nervous system |
| CPS |
Compendium of Pharmaceuticals and Specialties |
| Cr |
creatinine |
| CrCl |
creatinine clearance |
| CSF |
cerebrospinal fluid |
| CT |
computed tomography |
| DBL |
David Bull Laboratories |
| DEHP |
di-(2-ethylexyl)phthalate |
| DES |
diethylstilbestrol |
| DLCO |
pulmonary diffusion capacity for carbon monoxide |
| DNA |
deoxyribonucleic acid |
| D5-½NS |
dextrose 5% in ½ normal saline |
| D5NS |
dextrose 5% in normal saline |
| D5W |
dextrose 5% in water |
| ECG |
electrocardiogram |
| eg, |
for example |
| eps |
extrapyramidal symptoms |
| etc. |
et cetera, and so on |
| °F |
degrees Fahrenheit |
| FSH |
follicle-stimulating hormone |
| FVC |
forced vital capacity |
| g |
gram(s) |
| GFR |
glomerular filtration rate |
| GI |
gastrointestinal |
| GnRH |
gonadotropin-releasing hormone |
| h |
hour(s) |
| HPB |
Health Protection Branch |
| ie, |
that is |
| IM |
intramuscular |
| IT |
intrathecal |
| IU |
international unit(s) |
| IV |
intravenous |
| KCl |
potassium chloride |
| kg |
kilogram(s) |
| L |
litre(s) |
| LAP |
leucocyte alkaline phosphatase |
| LDH |
lactate dehydrogenase |
| LH |
luteinizing hormone |
| LHRH |
luteinizing hormone-releasing hormone |
| M |
molar |
| m² |
square metre |
| MAO |
monoamine oxidase |
| mcg |
microgram(s) |
| mEq |
milliequivalent(s) |
| mg |
milligram(s) |
| MgSO4 |
magnesium sulfate |
| min |
minute(s) |
| mL |
millilitre(s) |
| MRI |
magnetic resonance imaging |
| MU |
million units |
| NAD |
nicotinamide adenine dinucleotide |
| NADH |
nicotinamide adenine dinucleotide (reduced form) |
| NK cell |
natural killer cell |
| NS |
normal saline |
| NSABP |
National Surgical Adjuvant Breast and Bowel Project |
| NSAID |
nonsteroidal anti-inflammatory drug |
| PABA |
para-aminobenzoic acid |
| pH |
power of hydrogen (scale measuring acid/alkaline nature of solution) |
| po |
by mouth |
| PPB |
plasma protein binding |
| prn |
(pro re nata) as needed |
| PSA |
prostate-specific antigen |
| PVC |
polyvinyl chloride |
| qid |
four times a day |
| RBC |
red blood cell |
| RNA |
ribonucleic acid |
| s |
second(s) |
| SC |
subcutaneous |
| sec |
second(s) |
| SGOT |
serum glutamic-oxaloacetic transaminase (AST, aspartate aminotransferase) |
| SGPT |
serum glutamic-pyruvic transaminase (ALT, alanine aminotransferase) |
| SIADH |
syndrome of inappropriate secretion of antidiuretic hormone |
| SWI |
sterile water for injection (preservative-free) |
| t½ |
half-life |
| TB |
tuberculosis |
| TDD |
total digitalizing dose |
| tid |
three times a day |
| tiw |
three times a week |
| U |
unit(s) |
| µmol |
micromole(s) |
| USP |
United States Pharmacopoeia |
| VAD |
venous access device |
| Vd |
apparent volume of distribution |
| VIP |
vasoactive intestinal peptide |
| VOD |
veno-occlusive disease |
| WBC |
white blood cell |
| 2/3D-1/3NS |
2/3 dextrose 5% in 1/3 normal saline |
|
|
|
|